Novocure (NVCR), a global oncology company that employs TTFields to treat cancer, has a clinical trial catalyst to watch in the coming months.
The Tumor Treating Fields (TTFields) are electric fields that disrupt cancer cell division. The company is focused on the manufacture and commercialization of Tumor Treating Fields devices, designed to extend survival in some of the most aggressive forms of cancer. Its commercially available TTFields devices include Optune Gio and Optune Lua.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.